5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with Alloxan Diabetes in 1 studies
5-nitro-2-(3-phenylpropylamino)benzoic acid: structure given in first source; chloride channel antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tunstall, MJ | 1 |
| Eckert, R | 1 |
| Donaldson, P | 1 |
| Kistler, J | 1 |
1 other study available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Localised fibre cell swelling characteristic of diabetic cataract can be induced in normal rat lens using the chloride channel blocker 5-nitro-2-(3-phenylpropylamino) benzoic acid.
Topics: Animals; Aqueous Humor; Cataract; Chloride Channels; Corneal Edema; Diabetes Mellitus, Experimental; | 1999 |